Skip to content

Minister Warken Announces: Deliverance of Medicines Slated for the Autumn Season

Challenges in drug distribution surged immensely during the winter flu season, causing specific complications with medicine delivery.

Minister Warken announces medications to be distributed this fall
Minister Warken announces medications to be distributed this fall

Minister Warken Announces: Deliverance of Medicines Slated for the Autumn Season

In recent news, further EU regulations are planned to boost the production capacity of European medication. This move aims to ensure a steady supply of medicines across the continent.

Meanwhile, in Germany, the Anti-Shortage Law ('Anti-Kurzlieferungsgesetz'), enacted by the previous traffic light coalition government (SPD, Greens, FDP) in 2023, has played a significant role in addressing acute supply problems, particularly with children's medicines. The law eased price regulations and made deliveries to Germany more attractive for manufacturers, while also mandating stocks of several months' supply for widely used medicines as a safety buffer.

Currently, Federal Health Minister Nina Warken, a CDU politician, has stated that the availability of medicines this autumn and winter is stable, following earlier problems. She reaffirmed that the medication supply has a very high priority, both on a national and European level.

To further improve the management of medication supply, Minister Warken has proposed a reform that would give pharmacies more flexibility in exchanging suitable available medicines. This reform is intended to provide additional leeway for pharmacies in managing medication supply.

In addition, Minister Warken has reassured that the supply of medication is secured. The situation with children's medication, in particular, has shown significant improvement compared to previous years.

However, it's important to note that no specific mention has been made about the EU regulations' impact on Germany's medication supply or the stability of the supply this autumn and winter. Moreover, the Anti-Shortage Act and the mandatory stocks of several months' supply for widely used medicines were not explicitly mentioned in the minister's recent statements.

Despite these gaps in information, the focus remains on ensuring a stable and secure supply of medication, both in Germany and across Europe. The EU's efforts to enhance production capacity and the German government's ongoing reforms aim to address any potential issues and maintain the health and wellbeing of the population.

Read also:

Latest